Navigation Links
University of Georgia researchers show component of mothballs is present in deep-space clouds
Date:9/2/2009

y far the largest part of interstellar clouds, and carbon is another abundant element there. (This is known because scientists can measure their "light signals" or spectra and compare them to such spectra that can be generated in labs.) Still, it opens an entirely new area of study for astrophysicists and chemists who continue to understand the composition of space and the origins of the Universe.

Most people know naphthalene in its earthly crystalline form as C10H8, meaning it has 10 molecules of carbon and eight of hydrogen. The spectrum of this form of naphthalene does not match the UIRs. Duncan and his colleagues, however, had reason to believe that adding an extra proton to naphthalene (from the abundant hydrogen in space), which latches on in an unlikely space collision to give it the formula C10H9 +, might cause just the kind of change in its spectrum to match the UIR pattern.

To see if the component out there in space is protonated naphthalene, they had to first create it in the lab, under conditions near Absolute Zero and then zap it with a laser, turning it into a gas, whose infrared spectrum could then be analyzed. The bad news is that "infrared" refers to radiation whose wavelength is longer than that of visible light and so can't be seen by the naked eye. The good news is that the sophisticated machines in Duncan's lab can both "see" infrared spectrum, and identify what molecule produced it, allowing the distinctive spectrum of protonated naphthalene to be measure for the first time.

It turned out that when Duncan and his team did all this, the spectrum from their laboratory-created protonated naphthalene was almost identical to the spectrum seen in one part of the UIR.

What does it all mean? First, other scientists had found that interstellar dust is responsible for the production of molecular hydrogen from its atoms, which is the principal component of interstellar clouds. Other chemical processes taking place on th
'/>"/>

Contact: Philiip Lee Williams
phil@franklin.uga.edu
706-542-8501
University of Georgia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists from University of Hawaii at Manoa find genetic marker
2. Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed
3. Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University
4. University Mall Welcomes New Program Concept in Exercise & Wellness
5. Baylor University Economists Call for Different Tack on Health Care Insurance
6. Simcere Announces Strategic Partnership with Sun Yat-Sen University Cancer Center
7. Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials
8. Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials
9. Presidential Towers Donates Apartment to the University of Illinois Medical Center
10. Summer heat increases risk of amniotic fluid level deficiency, Ben-Gurion University study reveals
11. University Hospitals in Cleveland named one of the top 10 hospital systems in United States

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ALLEY, Pa., Dec. 1 Air P... the previously announced sale of the assets of it...er the Airthane® and Versathane® tradena...global polyurethane chemicals producer COIM SpA. ...acturing facility in Paulsboro, N.J. Terms of the ...
(Date:12/1/2009)...TON, Dec. 1 Individuals...likely than those with traditional coverage to exh...ore engaged in wellness programs, and to be more i...in holding down costs, according to survey results...t Research Institute (EBRI). ,, At the same ti...
(Date:12/1/2009)...IX, Dec. 1 Abrazo Media Relations-...sis ( http:// www.pedsorthopaedics.com ) located i...dic surgeon Dr. J. Hunt Udall to its practice. ,...thopaedic surgery after recently completing his fe... Massachusetts where he focused on adult and pedia...
(Date:12/1/2009)...AUDERDALE, Fla., Dec. 1 OrbusNeich...ent in the randomized clinical trial of the Combo ...t). ,, A prospective, randomized, multicenter s... ablu M inal sirolimus coat ED bio- E ngine...20 sites in Asia, Australia, Europe and South Amer...
(Date:12/1/2009)... The ADEAGies Foundation will honor The Forsyth I...the Gies Awards celebration to be held on February...the 2010 ADEA Annual Session & Exhibition. The Wil...hievement recognize contributions to, and support ...or a complete listing of Gies Award winners, visit...
Breaking Medicine News(10 mins):Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2
...inal Imaging System Allows Primary Care Physicians...l Images, WAKE FOREST, N.C., Sept. 19 Digital He...se management company based in Wake,Forest, NC, an...(R) technology platform. Retasure is a simple, af...
...IEW, Calif., Sept. 20 Cardiva Medical, Inc.,a pri...y that Augustine,Lien, Chairman and CEO, will pres... on Tuesday, September 25th in New York City. Nota...arket,clearance. This new product builds on the su...
...s Position as the Global Leader in Endoscopic Anti...Surgical, Inc. (NDO),announced that the US Food an...Plicator II(TM) multiple implant technology for im...This clearance and the subsequent launch of next-g...
...., Sept. 21 Cephalon, Inc. (Nasdaq:,CEPH) today a...ion (NDA) to,the U.S. Food and Drug Administration...tine HCl) for the treatment of patients with chron...e United States, according to the National Cancer ...
...) receives FDA clearance, REDMOND, Wash., Sept. 2...X(TM) device for performing Transoral Incisionless...troesophageal reflux,disease has received FDA clea...yesterday under general anesthesia,transoral, inci...
...IV Prof. Ehud Assia, of Tel Aviv Universitys Sack...ar in the field of eye surgery. , One of a small ...orm a complicated form of glaucoma surgery, Prof. ... give most practicing eye surgeons the ability to ...
Other Medicine News:Health News:Digital Healthcare Wins FDA Approval for Retasure 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:NDO Receives FDA 510(K) Clearance for Plicator II(TM) 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 3Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 4Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 2Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 3Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 4Health News:Glaucoma surgery in the blink of an eye 2
(Date:12/1/2009)...rts 90 percent radiation reduction in cardiac CT s... -- Dr. James Earls, a radiologist from Fairfax Ra.... will present the findings of a study that shows ...heart patients received from CT scans compared to ...ill present the study to the annual meeting of the...
(Date:12/1/2009)...ERRY HILL, N.J., Dec. 1 ...urprised and delighted when his radiotherapy treat...20 minutes each day to less than five. Midway thr...ware Valley Urology Cancer Center acquired the r...ogy from Varian Medical Systems (NYSE: VAR ), m...
(Date:12/1/2009)...E, Tenn., Dec. 1 Cumberl...d today that an independently conducted study of A...ous N-acetylcysteine, as a cost-saving treatment f... 12, Number 4 of the peer-reviewed Journal of Med...udy concludes that Acetadote is a less costly trea...
Breaking Medicine Technology:Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6Nanoparticles used in common household items caused genetic damage in mice 10748 1Nanoparticles used in common household items caused genetic damage in mice 10748 2Nanoparticles used in common household items caused genetic damage in mice 10748 3Teen Girls at Higher Risk for STDs 3A Report 61460 1Teen Girls at Higher Risk for STDs 3A Report 61460 2Immunity to Swine Flu May Be Broader Than Thought 61457 1Immunity to Swine Flu May Be Broader Than Thought 61457 2Immunity to Swine Flu May Be Broader Than Thought 61457 3
...Congress of European Hematology,Association (EHA) ...tCall/ --,Immunomedics, Inc. , a biopharmaceutical...es to treat cancer and other serious,diseases, tod...ess,of EHA in Vienna, Austria, showed positive res...L) treated with a new,radioimmunotherapy (RAIT) us...
...ivational Reserve" May Also Affect,Alzheimer,s Ris...ire/ -- A new study,suggests that treating risk fa...lood pressure and diabetes, may slow the progressi...eported today at the,2nd Alzheimer,s Association I...in Washington, DC. , Two new studies presented at ...
Other Medicine Technology:Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 2Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 3Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 4Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 6Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 7
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: